GlassScriptPhysician profile
Jeffrey T Striet
NPI 1275744682
$13,035.53
in general payments reported to CMS, 2019-2025
37 companies · $803 in 2025
The $803 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,272 · 2020: $1,781 · 2021: $3,093 · 2022: $2,566 · 2023: $1,367 · 2024: $1,154 · 2025: $803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,323.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,479.67 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $2,357.20 | 2019-2025 | |
| Imperative Care, INC | $1,283.01 | 2024-2025 | Symphony Catheter, Prodigy Catheter |
| Astrazeneca Pharmaceuticals LP | $1,118.04 | 2019-2023 | Farxiga, Brilinta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $759.95 | 2019-2023 | Jardiance |
| Amgen INC. | $742.27 | 2019-2023 | Repatha |
| Amarin Pharma, INC. | $491.30 | 2019-2022 | |
| Pfizer INC. | $413.63 | 2019-2023 | |
| Boston Scientific Corporation | $377.59 | 2019-2023 | Varithena Administration Pack |
| Merck Sharp & Dohme LLC | $375.48 | 2021-2023 | Verquvo |
| Esperion Therapeutics, INC. | $292.58 | 2020-2023 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $273.01 | 2019-2024 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $241.46 | 2021-2023 | |
| Abbott Laboratories | $228.60 | 2020-2024 | Cardiomems |
| Actelion Pharmaceuticals US, INC. | $172.50 | 2019-2023 | Opsumit, Uptravi |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braemar Manufacturing, LLC | $151.36 | 2019 | |
| Astellas Pharma US INC | $149.40 | 2020-2021 | |
| Daiichi Sankyo INC. | $148.18 | 2019-2022 | |
| Philips North America LLC | $141.47 | 2020-2024 | (Ck7) Extended Holter |
| Vifor Pharma, INC. | $126.79 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $125.83 | 2019 | |
| Abiomed | $86.47 | 2024-2025 | Impella |
| Bardy Diagnostics, INC. | $70.00 | 2020 | |
| Chiesi USA, INC. | $61.21 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $58.72 | 2019 | |
| Lundbeck LLC | $56.73 | 2019 | |
| Edwards Lifesciences Corporation | $48.65 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $35.82 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $24.08 | 2024 | Assure Wcd |
| Gilead Sciences, INC. | $22.13 | 2019 | |
| Akcea Therapeutics, INC. | $21.70 | 2020 | |
| Angiodynamics, INC. | $21.61 | 2023 | Auryon Laser System 100-120 Vac |
| Cordis US Corp. | $17.62 | 2025 | Mynx Control Venous |
| Recor Medical INC | $16.97 | 2025 | Paradise Ultrasound Renal Denervation System |
| Lexicon Pharmaceuticals, INC. | $16.87 | 2023 | Inpefa |
| Baxter Healthcare | $16.06 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Elutia, INC. | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Striet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.